ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

NTLA Intellia Therapeutics Inc

23.10
0.10 (0.43%)
プレマーケット
最終更新日: 20:30:00
15分遅延
名称 銘柄コード 市場 種別
Intellia Therapeutics Inc NTLA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.10 0.43% 23.10 20:30:00
始値 安値 高値 終値 前日終値
23.00
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0920:40EDGAR2Form 8-K - Current report
2024/5/0920:30GLOBEIntellia Therapeutics Announces First Quarter 2024 Financial..
2024/5/0220:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
2024/4/2920:30GLOBEIntellia Therapeutics to Present Updated Data from Phase 1/2..
2024/3/1820:30GLOBEIntellia Therapeutics Announces First Patient Dosed in the..
2024/3/0606:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2621:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2407:17EDGAR2Form 8-K - Current report
2024/2/2306:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2306:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2221:45EDGAR2Form 8-K - Current report
2024/2/2221:30GLOBEIntellia Therapeutics Announces Fourth Quarter and Full-Year..
2024/2/1521:30GLOBEIntellia Therapeutics and ReCode Therapeutics Announce..
2024/2/1421:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
2024/2/0206:05EDGAR2Form 8-K - Current report
2024/2/0107:00GLOBEIntellia Therapeutics Announces Publication of Positive..
2024/1/3006:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1106:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0906:05EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0606:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:07EDGAR2Form 8-K - Current report
2024/1/0506:01GLOBEIntellia Therapeutics Highlights its Three-Year Strategic..
2024/1/0407:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0621:00EDGAR2Form 8-K - Current report
2023/11/2423:30EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/1421:30GLOBEIntellia Therapeutics Receives European Union Orphan Drug..
2023/11/1006:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:45EDGAR2Form 8-K - Current report
2023/11/0921:30GLOBEIntellia Therapeutics Announces Third Quarter 2023 Financial..
2023/11/0305:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0220:11EDGAR2Form 8-K - Current report
2023/11/0220:00GLOBEIntellia Presents New Interim Data from the Ongoing Phase 1..
2023/10/2620:30GLOBEIntellia Therapeutics to Present Updated Data from Ongoing..
2023/10/1820:30EDGAR2Form 8-K - Current report
2023/10/1820:00GLOBEIntellia Therapeutics Announces FDA Clearance of..
2023/10/1321:38GLOBEIntellia Therapeutics Receives Priority Medicines (PRIME)..
2023/10/0320:19EDGAR2Form 8-K - Current report
2023/10/0320:00GLOBERegeneron and Intellia Announce Expanded Research..
2023/8/0405:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0320:45EDGAR2Form 8-K - Current report
2023/8/0320:30GLOBEIntellia Therapeutics Announces Second Quarter 2023..

最近閲覧した銘柄

Delayed Upgrade Clock